Guodong Gao

Yihong Guo, Junjie Luo, Guodong Gao et al.

Offline contextual bandits allow one to learn policies from historical/offline data without requiring online interaction. However, offline policy optimization that maximizes overall expected rewards can unintentionally amplify the reward disparities across groups. As a result, some groups might benefit more than others from the learned policy, raising concerns about fairness, especially when the resources are limited. In this paper, we study a group-sensitive fairness constraint in offline contextual bandits, reducing group-wise reward disparities that may arise during policy learning. We tackle the following common-parity requirements: the reward disparity is constrained within some user-defined threshold or the reward disparity should be minimized during policy optimization. We propose a constrained offline policy optimization framework by introducing group-wise reward disparity constraints into an off-policy gradient-based optimization procedure. To improve the estimation of the group-wise reward disparity during training, we employ a doubly robust estimator and further provide a convergence guarantee for policy optimization. Empirical results in synthetic and real-world datasets demonstrate that our method effectively reduces reward disparities while maintaining competitive overall performance.

Jinhe Shi, Xiangyu Gao, Chenyu Ha et al.

Adverse drug events (ADEs) are a serious health problem that can be life-threatening. While a lot of studies have been performed on detect correlation between a drug and an AE, limited studies have been conducted on personalized ADE risk prediction. Among treatment alternatives, avoiding the drug that has high likelihood of causing severe AE can help physicians to provide safer treatment to patients. Existing work on personalized ADE risk prediction uses the information obtained in the current medical visit. However, on the other hand, medical history reveals each patient's unique characteristics and comprehensive medical information. The goal of this study is to assess personalized ADE risks that a target drug may induce on a target patient, based on patient medical history recorded in claims codes, which provide information about diagnosis, drugs taken, related medical supplies besides billing information. We developed a HTNNR model (Hierarchical Time-aware Neural Network for ADE Risk) that capture characteristics of claim codes and their relationship. The empirical evaluation show that the proposed HTNNR model substantially outperforms the comparison methods, especially for rare drugs.